Cargando…

Type 2 diabetes pharmacotherapy trends in high‐risk subgroups

Medication use trends among patients with type 2 diabetes from 2015 to 2019 were investigated in relation to the clinical group‐specific recommendations from the 2018 American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) consensus report. Data were drawn from a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Jay, Liu, Dongju, Chinthammit, Chanadda, Kadziola, Zbigniew, Boye, Kristina, Mather, Kieren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314938/ https://www.ncbi.nlm.nih.gov/pubmed/35243741 http://dx.doi.org/10.1111/dom.14678

Ejemplares similares

An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations
por: Bae, Jay P., et al.
Publicado: (2022)

Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States
por: Bajpai, Sanjay, et al.
Publicado: (2021)

FRI639 Effect Of Early Initiation Of GLP-1 RAs On Weight Reduction Among People With Type 2 Diabetes
por: Chinthammit, Chanadda, et al.
Publicado: (2023)

Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019
por: Boye, Kristina S., et al.
Publicado: (2021)

Current Procedural Terminology Codes for Medication Therapy Management in Administrative Data
por: Axon, David R., et al.
Publicado: (2020)

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
por: Heise, Tim, et al.
Publicado: (2023)

Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample
por: Campbell, Patrick J., et al.
Publicado: (2021)

Emerging Trend in the Pharmacotherapy of Osteoarthritis
por: Zhang, Wei, et al.
Publicado: (2019)

Current Trends in the Pharmacotherapy of Cataracts
por: Heruye, Segewkal H., et al.
Publicado: (2020)

Weight management treatment modalities in patients with overweight or obesity: A retrospective cohort study of administrative claims data
por: Kan, Hong, et al.
Publicado: (2023)

Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study
por: Chinthammit, Chanadda, et al.
Publicado: (2021)

Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region
por: Chinthammit, Chanadda, et al.
Publicado: (2020)

Evaluation of a guided continuous quality improvement program in community pharmacies
por: Chinthammit, Chanadda, et al.
Publicado: (2017)

Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes
por: Aggarwal, Naresh, et al.
Publicado: (2017)

Preventive pharmacotherapy in type 2 diabetes mellitus
por: Choudhary, Neeraj, et al.
Publicado: (2012)

Weight Considerations in Pharmacotherapy for Type 2 Diabetes
por: Cheng, Vicky, et al.
Publicado: (2011)

Obesity Pharmacotherapy in Patients With Type 2 Diabetes
por: Kahan, Scott, et al.
Publicado: (2017)

Incidence trends for childhood type 1 diabetes in India
por: Kumar, Kanakatte Mylariah Prasanna
Publicado: (2015)

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
por: Smith-Palmer, Jayne, et al.
Publicado: (2016)

Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection
por: Vitiello, Antonio, et al.
Publicado: (2022)

Associations of Renin‐Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort Study
por: Campbell, Patrick J., et al.
Publicado: (2020)

Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes
por: Iwamoto, Noriyuki, et al.
Publicado: (2017)

Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
por: Onishi, Yukiko, et al.
Publicado: (2020)

Digital lifestyle treatment improves long-term metabolic control in type 2 diabetes with different effects in pathophysiological and genetic subgroups
por: Salunkhe, Vishal A., et al.
Publicado: (2023)

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program
por: Billings, Liana K., et al.
Publicado: (2018)

Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders
por: Badenoch, James, et al.
Publicado: (2020)

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study
por: Calhoun, Peter, et al.
Publicado: (2021)

Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy
por: Bae, Hwallip, et al.
Publicado: (2018)

Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
por: Xu, James, et al.
Publicado: (2017)

Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin
por: Peng, Xiaomei, et al.
Publicado: (2016)

Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials
por: Yamada, Yuichiro, et al.
Publicado: (2021)

Novel Pharmacotherapies in Diabetic Retinopathy
por: Dedania, Vaidehi S., et al.
Publicado: (2015)

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
por: Soghomonyan, S., et al.
Publicado: (2021)

Recruitment effort and costs from a multi-center randomized controlled trial for treating depression in type 2 diabetes
por: Myers, Barbara A., et al.
Publicado: (2019)

Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
por: Ugowe, Francis E., et al.
Publicado: (2021)

Population Subgroups at Risk of Unhealthy Changes in Food and Beverage Consumption During COVID-19 Lockdowns
por: Booth, Leon, et al.
Publicado: (2023)

Prevalence of and Trends in Diabetes Among Veterans, United States, 2005–2014
por: Liu, Ying, et al.
Publicado: (2017)

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
por: Tschöpe, Diethelm, et al.
Publicado: (2013)

An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
por: Mahgoub, Mohamed Omer, et al.
Publicado: (2023)

Cell-Free DNA Fragments as Biomarkers of Islet β-Cell Death in Obesity and Type 2 Diabetes
por: Arosemena, Marilyn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6oq67a1n0koagnr3pf44a1t4ud